Latest therapeutics News | Page 17

Brendan Crabb: Australia’s $85 million commitment to COVAX welcomed
University of Toronto partners with Moderna to advance research in RNA science and technology
Open to all, anytime, anywhere: Free online courses bring vaccine knowledge to global community
Broadening and scaling reach of mRNA vaccines
International partnership may hold key to new cancer therapies
John Dick and Zulfiqar Bhutta win Canada Gairdner Awards
Microba announces new research partnership and senior appointment
NCI-COG Pediatric MATCH study shows benefit of genetic screening in refractory tumors
Key protein facilitates regeneration of liver blood vessels
Cooperative Research Australia Excellence in Innovation Award winners revealed at gala event at Parliament House
Avecho reports positive results for Phase 2 topical CBD osteoarthritis study
Cancer Therapeutics CRC/Canthera Discovery next generation drugs land CRA Award for Research Commercialisation
Using organ-on-a-chip platform, researchers devise potential strategy to treat severe Covid complications
Promising nose spray could prevent and treat Covid
Alpaca nanobodies potently neutralize SARS-CoV-2 variants
Molecular key may unlock new treatments for neurodegenerative disorders
In Animal Study, Implant Churns Out CAR-T Cells to Combat Cancer
Large molecule facility doubles size of leading bioanalytical laboratory
Industry concerned by leaked Covid vaccine IP waiver text
Doherty Institute secures landmark agreement with Moderna to expedite vaccine research for infectious diseases
$32m for groundbreaking projects combining industry and research
Potential new Covid immunotherapy could protect vulnerable
Preparedness gains through PIP PC
Victoria And Abu Dhabi Sign Research And Investment Partnership
Australia and Korea sign MoU on vaccine research
Victoria Strengthens Ties With Pfizer To Boost Skills
Enzyme could be new target for cancer immunotherapies
Programming Immune System to Supercharge Cancer Cell Therapies
Stronger for Longer Scholarships support QUT’s ground-breaking prostate cancer research
Seven takeaways from University of Toronto Entrepreneurship Week 2022
Startups focused on health, sustainability among winners at Entrepreneurship Week pitch competition
Rebrand for Australia’s largest life sciences venture fund
WHO Global Health Facilities Database: Ensuring access to primary healthcare and UHC
Vital cellular research wins Gottschalk Medal
Shot in arm for global vaccine development
Chimeric Therapeutics announces final results from Phase 1 trial of CORE NK Platform
Eighth Meeting of Multilateral Leaders Task Force on COVID-19, 1 March 2022
Antisense Therapeutics confirms ATL1102 poster presentation
WHO and MPP welcome NIH’s offer of Covid health technologies to C-TAP
WHO updates its treatment guidelines to include molnupiravir
Cell research on rare disease finds new link to inflammation
Rebooting evolution with new software
Kazia Therapeutics to be ‘transformed’ by pipeline progress
Five things to look forward to at Entrepreneurship Week 2022
More than vaccines: University of Toronto researcher investigates future of mRNA therapeutics
Arovella Therapeutics closes over-subscribed share purchase plan
Statement on Omicron sublineage BA.2
Top 3 Covid vaccine questions – anxiety with open borders, triple vaccinations, and child vaccinations